Literature DB >> 18174514

Facial affect recognition in individuals at clinical high risk for psychosis.

Jean Addington1, David Penn, Scott W Woods, Donald Addington, Diana O Perkins.   

Abstract

Facial affect discrimination and identification were assessed in 86 clinical high-risk individuals and compared with 50 individuals with first-episode psychosis, 53 with multi-episode schizophrenia and 55 non-psychiatric controls. On the identification task the non-psychiatric controls performed significantly better than all other groups, and on discrimination significantly better than both patient groups. Deficits in facial affect recognition appear to be present before the onset of psychosis and may be a vulnerability marker.

Entities:  

Mesh:

Year:  2008        PMID: 18174514      PMCID: PMC2423816          DOI: 10.1192/bjp.bp.107.039784

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Facial affect recognition: a mediator between cognitive and social functioning in psychosis?

Authors:  Jean Addington; Huma Saeedi; Donald Addington
Journal:  Schizophr Res       Date:  2006-05-05       Impact factor: 4.939

3.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

4.  Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance?

Authors:  S L Kerr; J M Neale
Journal:  J Abnorm Psychol       Date:  1993-05

5.  Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

Authors:  Alison R Yung; Hok Pan Yuen; Gregor Berger; Shona Francey; Te-Chieh Hung; Barnaby Nelson; Lisa Phillips; Patrick McGorry
Journal:  Schizophr Bull       Date:  2007-04-02       Impact factor: 9.306

6.  Facial affect recognition and information processing in schizophrenia and bipolar disorder.

Authors:  J Addington; D Addington
Journal:  Schizophr Res       Date:  1998-08-17       Impact factor: 4.939

7.  Emotion perception and social skill over the course of psychosis: a comparison of individuals "at-risk" for psychosis and individuals with early and chronic schizophrenia spectrum illness.

Authors:  Amy E Pinkham; David L Penn; Diana O Perkins; Karen A Graham; Monica Siegel
Journal:  Cogn Neuropsychiatry       Date:  2007-05       Impact factor: 1.871

8.  Do the siblings of schizophrenia patients demonstrate affect perception deficits?

Authors:  Kimmy S Kee; William P Horan; Jim Mintz; Michael F Green
Journal:  Schizophr Res       Date:  2004-03-01       Impact factor: 4.939

  8 in total
  63 in total

1.  Out of touch with reality? Social perception in first-episode schizophrenia.

Authors:  Sjoerd J H Ebisch; Anatolia Salone; Francesca Ferri; Domenico De Berardis; Gian Luca Romani; Filippo M Ferro; Vittorio Gallese
Journal:  Soc Cogn Affect Neurosci       Date:  2012-01-24       Impact factor: 3.436

2.  Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Authors:  Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Bull       Date:  2015-09       Impact factor: 9.306

3.  Theory of Mind in patients at clinical high risk for psychosis.

Authors:  Arielle D Stanford; Julie Messinger; Dolores Malaspina; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2011-07-14       Impact factor: 4.939

4.  Assessment of social judgments and complex mental states in the early phases of psychosis.

Authors:  Shannon M Couture; David L Penn; Jean Addington; Scott W Woods; Diana O Perkins
Journal:  Schizophr Res       Date:  2008-02-05       Impact factor: 4.939

5.  Limbic activity in antipsychotic naïve first-episode psychotic subjects during facial emotion discrimination.

Authors:  Daniel Bergé; Susanna Carmona; Purificación Salgado; Mariana Rovira; Antoni Bulbena; Oscar Vilarroya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-21       Impact factor: 5.270

6.  Neural Mechanisms Underlying Affective Theory of Mind in Violent Antisocial Personality Disorder and/or Schizophrenia.

Authors:  Boris Schiffer; Christina Pawliczek; Bernhard W Müller; Jens Wiltfang; Martin Brüne; Michael Forsting; Elke R Gizewski; Norbert Leygraf; Sheilagh Hodgins
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

Review 7.  Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention.

Authors:  Sheilagh Hodgins
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-08-12       Impact factor: 6.237

8.  Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.

Authors:  C M Corcoran; J G Keilp; J Kayser; C Klim; P D Butler; G E Bruder; R C Gur; D C Javitt
Journal:  Psychol Med       Date:  2015-06-04       Impact factor: 7.723

9.  Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia.

Authors:  Wolfgang Wölwer; Jürgen Brinkmeyer; Sanna Stroth; Marcus Streit; Andreas Bechdolf; Stephan Ruhrmann; Michael Wagner; Wolfgang Gaebel
Journal:  Schizophr Bull       Date:  2011-03-14       Impact factor: 9.306

10.  Neurodevelopmental Genomic Strategies in the Study of the Psychosis Spectrum.

Authors:  Raquel E Gur
Journal:  Nebr Symp Motiv       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.